Literature DB >> 3383447

Critical dependence on antibody for defence against mycoplasmas.

A D Webster1, P M Furr, N C Hughes-Jones, B D Gorick, D Taylor-Robinson.   

Abstract

We have shown that mycoplasmas bind spontaneously to neutrophils, as well as directly activating the first component of complement with probable subsequent binding through neutrophil complement receptors. Thus, antibody is not required to opsonize mycoplasmas for neutrophil phagocytosis. Furthermore, mycoplasmas remain viable when phagocytosed in the absence of antibody and may be carried inside neutrophils to various parts of the body to cause infection (e.g. joints). We found that antibody alone inhibits the growth of mycoplasmas in vitro. These observations suggest that the role of antibodies is to control the growth of mycoplasmas on mucosal surfaces; neutrophils play no part in defence and may even aid dissemination of the infection. This helps to explain why patients with hypogammaglobulinaemia are prone to systemic mycoplasma infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3383447      PMCID: PMC1541675     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Interactions between Mycoplasma pneumoniae and guinea pig complement.

Authors:  W Bredt; D Bitter-Suermann
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

2.  Ultrastructural lesions in Mycoplasma pneumoniae membranes produced by antibody and complement.

Authors:  H Brunner; A R Kalica; W D James; R L Horswood; R M Chanock
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

3.  Neonatal central nervous system infection due to Mycoplasma hominis.

Authors:  G R Siber; S Alpert; A L Smith; J S Lin; W M McCormack
Journal:  J Pediatr       Date:  1977-04       Impact factor: 4.406

Review 4.  The genital mycoplasmas (first of two parts).

Authors:  D Taylor-Robinson; W M McCormack
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

5.  The measurement of opsonic and phagocytic function by Luminol-dependent chemiluminescence.

Authors:  C S Easmon; P J Cole; A J Williams; M Hastings
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

6.  The binding and activation of the Clr-Cls subunit of the first component of human complement.

Authors:  N C Hughes-Jones; B D Gorick
Journal:  Mol Immunol       Date:  1982-09       Impact factor: 4.407

7.  Ureaplasma urealyticum causing persistent urethritis in a patient with hypogammaglobulinaemia.

Authors:  D Taylor-Robinson; P M Furr; A D Webster
Journal:  Genitourin Med       Date:  1985-12

8.  Serum factors for opsonisation of non-typable Haemophilus influenzae.

Authors:  A M Lever; J Gross; A D Webster
Journal:  J Med Microbiol       Date:  1985-08       Impact factor: 2.472

9.  Chronic cystitis and urethritis associated with ureaplasmal and mycoplasmal infection in primary hypogammaglobulinaemia.

Authors:  A D Webster; D Taylor-Robinson; P M Furr; G L Asherson
Journal:  Br J Urol       Date:  1982-06

10.  Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia.

Authors:  C M Roifman; C P Rao; H M Lederman; S Lavi; P Quinn; E W Gelfand
Journal:  Am J Med       Date:  1986-04       Impact factor: 4.965

View more
  14 in total

1.  Interaction of campylobacter species with antibody, complement and phagocytes.

Authors:  E Bernatowska; P Jose; H Davies; M Stephenson; D Webster
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

Review 2.  Alternative therapy for genital mycoplasma infections.

Authors:  J A Robertson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

3.  Amniotic fluid neutrophils can phagocytize bacteria: A mechanism for microbial killing in the amniotic cavity.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Valeria Garcia-Flores; Yi Xu; Yaozhu Leng; Ali Alhousseini; Sonia S Hassan; Bogdan Panaitescu
Journal:  Am J Reprod Immunol       Date:  2017-07-13       Impact factor: 3.886

4.  Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro.

Authors:  G Piec; J Mirkovitch; S Palacio; P F Mühlradt; R Felix
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Septic osteomyelitis and polyarthritis with ureaplasma in hypogammaglobulinemia.

Authors:  C Jorup-Rönström; T Ahl; L Hammarström; C I Smith; M Rylander; H Hallander
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

6.  Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years.

Authors:  P M Furr; D Taylor-Robinson; A D Webster
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

7.  Chronic bronchitis in immunocompromised patients: association with a novel Mycoplasma species.

Authors:  D Webster; H Windsor; C Ling; D Windsor; D Pitcher
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-26       Impact factor: 3.267

Review 8.  Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.

Authors:  G H Cassell; K B Waites; H L Watson; D T Crouse; R Harasawa
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

Review 9.  Osteoarticular infectious complications in patients with primary immunodeficiencies.

Authors:  Katherine A Bloom; Danna Chung; Charlotte Cunningham-Rundles
Journal:  Curr Opin Rheumatol       Date:  2008-07       Impact factor: 5.006

10.  Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells.

Authors:  Kathryn Chmura; Xiyuan Bai; Mari Nakamura; Pitchaimani Kandasamy; Mischa McGibney; Koji Kuronuma; Hiroki Mitsuzawa; Dennis R Voelker; Edward D Chan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-16       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.